Not Yet Recruiting OBSERVATIONAL NCT06463223

HIBOC = Hepatic Imaging Biomarkers in Obese Children

Imaging-based Biomarkers for Liver Disease in Children With Obesity-a Longitudinal Study

Sponsor: Sahlgrenska University Hospital

Conditions Attenuation Imaging Child Obesity Diagnosis Elastography Fibrosis, Liver Inflammation; Liver Metabolic Disease Metabolic and Genetic Disorder Affecting the Liver Shear Wave Dispersion Shear Wave Elastography Steatosis

Updated 4 times since 2024 Last updated: Jun 16, 2024 Started: Oct 31, 2024 Primary completion: Dec 31, 2028 Completion: Dec 31, 2029

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT06463223, this observational or N/A phase trial focuses on Attenuation Imaging and Child Obesity and remains actively recruiting participants. Sponsored by Sahlgrenska University Hospital, it has been updated 4 times since 2024, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

4 versions recorded

Mar 2025 — Present [monthly]

Not Yet Recruiting
Feb 2025 — Mar 2025 [monthly]

Not Yet Recruiting
Sep 2024 — Feb 2025 [monthly]

Not Yet Recruiting
Jul 2024 — Sep 2024 [monthly]

Not Yet Recruiting

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Sahlgrenska University Hospital

Data source: Sahlgrenska University Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.